Follow
Motahareh Mahi birjand
Motahareh Mahi birjand
Infectious Diseases Research Center, Birjand University of Medical Sciences, Birjand, Iran
Verified email at bums.ac.ir
Title
Cited by
Cited by
Year
Potential drugs used in the antibody–drug conjugate (ADC) architecture for cancer therapy
S Yaghoubi, MH Karimi, M Lotfinia, T Gharibi, M Mahi‐Birjand, E Kavi, ...
Journal of cellular physiology 235 (1), 31-64, 2020
1282020
Protective effects of pharmacological agents against aminoglycoside-induced nephrotoxicity: A systematic review
M Mahi-Birjand, S Yaghoubi, M Abdollahpour-Alitappeh, Z Keshtkaran, ...
Expert Opinion on Drug Safety 19 (2), 167-186, 2020
532020
How hypoxia regulate exosomes in ischemic diseases and cancer microenvironment?
S Yaghoubi, H Najminejad, M Dabaghian, MH Karimi, ...
IUBMB life 72 (7), 1286-1305, 2020
352020
Optimizing compliance with surgical antimicrobial prophylaxis guidelines in patients undergoing gastrointestinal surgery at a referral teaching hospital in southern Iran …
L Mahmoudi, M Ghouchani, M Mahi-Birjand, A Bananzadeh, A Akbari
Infection and drug resistance, 2437-2444, 2019
272019
Ceftriaxone-associated nephrolithiasis and gallstone in adults
G Azarkar, MM Birjand, A Ehsanbakhsh, B Bijari, MR Abedini, M Ziaee
Drug, healthcare and patient safety, 103-108, 2018
202018
Key regulatory miRNAs and their interplay with mechanosensing and mechanotransduction signaling pathways in breast cancer progression
H Najminejad, B Farhadihosseinabadi, M Dabaghian, A Dezhkam, ...
Molecular Cancer Research 18 (8), 1113-1128, 2020
92020
Evaluation of vancomycin therapy in the adult ICUs of a teaching hospital in southern Iran
A Vazin, M Mahi Birjand, M Darake
Drug, Healthcare and Patient Safety, 21-26, 2018
82018
Investigating the sequential patterns of methamphetamine use initiation in Iran
EM Sarani, J Ahmadi, B Oji, M Mahi-Birjand, N Bagheri, A Bazrafshan, ...
Substance Abuse Treatment, Prevention, and Policy 15, 1-10, 2020
72020
Protective effects of silymarin on gentamicin-induced nephrotoxicity in infectious patients: a randomized double blinded placebo-controlled clinical trial
M Mahi-Birjand, I Karimzadeh, A Zarban, M Abdollahpour-Alitappeh, ...
Pharmaceutical Sciences 26 (3), 287-295, 2020
62020
Evaluation of vancomycin use in university-affiliated hospitals in Southern Khorasan Province (East Iran) based on HICPAC guidelines
M Mahi-Birjand, M Ziaee, B Bijari, R Khalvati, MR Abedini, ...
Drug, Healthcare and Patient Safety, 29-35, 2019
52019
Performance of drug and poison information center within a Referral University hospital in southwest of Iran
I Karimzadeh, A Vazin, N Talebnia, N Hatami-Mazinani, M Mahi-Birjand
Journal of Pharmaceutical Care, 49-55, 2017
42017
Comparison of intravenous sodium bicarbonate and sodium chloride combination versus intravenous sodium chloride hydration alone in reducing amphotericin B nephrotoxicity: a …
I Karimzadeh, A Sepehr-Sobhani, MJ Khoshnoud, MM Sagheb, R Vejdani, ...
Research in Pharmaceutical Sciences 15 (6), 583-591, 2020
32020
Catastrophic pharmaceutical expenditure in patients with type 2 diabetes in Iran
L Zarei, N Moradi, F Peiravian, N Hatami-Mazinani, M Mahi-Birjand, ...
International Journal for Equity in Health 21 (1), 188, 2022
12022
Assessing the performance of community pharmacies in Iran by measuring responsiveness to non-medical needs: An application of WHO responsiveness framework
S Afifi, AHA Bahmani, L Zarei, M Mahi-Birjand, M Hoorang, M Zare, ...
Journal of research in pharmacy practice 10 (2), 59-64, 2021
12021
Aminoglycosides: Single-or Multiple-daily Dosing? An Updated Qualitative Systematic Review of Randomized Trials on Toxicity and Efficacy
I Karimzadeh, M Abdollahpour-Alitappeh, S Ghaffari, M Mahi-Birjand, ...
Current Molecular Medicine, 2024
2024
Compliance with Antibiotics Prophylaxis Guideline in Surgical Patients in ICUs of a Teaching Referral Hospital
A Vazin, N Hatami-Mazinani, E Alemzadeh, F Dehghani, M Mahi-Birjand
Health Services Insights 15, 11786329221136437, 2022
2022
Comparison between Management and Pharmacotherapy of COVID-19 in Iran and Switzerland: Management and Pharmacotherapy of COVID-19 in Iran and Switzerland
P Peymani, S Bazdar, L Zarei, M Hoorang, N Hatami-Mazinani, ...
Novelty in Biomedicine 10 (4), 219-225, 2022
2022
Cover Image, Volume 235, Number 1, January 2020
S Yaghoubi, MH Karimi, M Lotfinia, T Gharibi, M Mahi‐Birjand, E Kavi, ...
Journal of Cellular Physiology 235 (1), i-i, 2020
2020
The system can't perform the operation now. Try again later.
Articles 1–18